XML 49 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed The purchase price was allocated as follows (in thousands):
Assets Acquired
 
Trade receivables
$
958

Inventories
2,157

Prepaid expenses and other assets
85

Property and equipment
1,472

Intangibles
 
Developed technology
21,100

Customer lists
700

Trademarks
2,900

Goodwill
8,989

Total assets acquired
38,361

 
 
Liabilities Assumed
 
Trade payables
(338
)
Accrued expenses
(23
)
Total liabilities assumed
(361
)
 
 
Net assets acquired
$
38,000

The purchase price was preliminarily allocated as follows (in thousands):
Inventories
$
1,308

Intangibles
 
Developed technology
32,830

Customer list
840

Trademarks
1,410

Goodwill
21,832

 
 
Total assets acquired
$
58,220

The following table summarizes the purchase price allocated to the net tangible and intangible assets acquired and liabilities assumed (in thousands):
 
Assets Acquired
 
 
Cash and cash equivalents
$
1,436

 
Trade receivables
8,351

 
Inventories
11,222

 
Prepaid expenses and other assets
1,275

 
Income tax refund receivable
165

 
Property and equipment
2,319

 
Deferred tax assets
202

 
Intangibles
 
 
Developed technology
2,200

 
Customer lists
1,500

 
Trademarks
900

 
Total assets acquired
29,570

 
 
 
 
Liabilities Assumed
 
 
Trade payables
(2,414
)
 
Accrued expenses
(5,083
)
 
Income taxes payable

 
Deferred income tax liabilities
(934
)
 
Total liabilities assumed
(8,431
)
 
 
 
 
Total net assets acquired
21,139

 
Gain on bargain purchase (1)
(11,039
)
 
Total purchase price
$
10,100

 
 
 
(1)
The total fair value of the net assets acquired from Argon exceeded the purchase price, resulting in a gain on bargain purchase which was recorded within other income (expense) in our consolidated statements of income. We believe the reason for the gain on bargain purchase was a result of the divestiture of a non-strategic, slow-growth critical care business for Argon. It is our understanding that the divestiture allows Argon to focus on its higher growth interventional portfolio.
The following table summarizes the aggregate purchase price (including contingent royalty payment liabilities) allocated to the assets acquired from Laurane (in thousands):
 
Inventories
$
594

 
Intangibles
 
 
Developed technology
14,920

 
Customer list
120

 
Goodwill
6,366

 
 
 
 
Total net assets acquired
$
22,000

The purchase price was allocated to the net tangible and intangible assets acquired and liabilities assumed, based on estimated fair values, as follows (in thousands):
Assets Acquired
 
Trade receivables
$
4,054

Other receivables
6

Inventories
8,585

Prepaid expenses
630

Property and equipment
1,630

Other long-term assets
145

Intangibles
 
Developed technology
67,600

Customer lists
2,400

Trademarks
4,400

Goodwill
24,818

Total assets acquired
114,268

 
 
Liabilities Assumed
 
Trade payables
(1,790
)
Accrued expenses
(5,298
)
Deferred income tax liabilities - current
(701
)
Deferred income tax liabilities - noncurrent
(10,844
)
Total liabilities assumed
(18,633
)
 
 
Net assets acquired, net of cash received of $1,327
$
95,635

The purchase price was preliminarily allocated as follows (in thousands):
Inventories
$
971

Intangibles
 
Developed technology
4,840

Customer list
120

Trademarks
400

Goodwill
938

 
 
Total assets acquired
$
7,269

The following table summarizes the aggregate purchase price allocated to the assets acquired from ITL (in thousands):
Assets Acquired
 
Trade receivables
$
1,287

Other receivables
56

Inventories
1,808

Prepaid expenses and other assets
65

Property and equipment
1,053

Intangibles
 
Customer lists
5,940

Goodwill
3,945

Total assets acquired
14,154

 
 
Liabilities Assumed
 
Trade payables
(216
)
Accrued expenses
(747
)
Deferred tax liabilities
(1,901
)
Total liabilities assumed
(2,864
)
 
 
Total net assets acquired
$
11,290

The purchase price was allocated as follows (in thousands):
Assets Acquired
 
Inventories
$
2,455

Property and equipment
290

Intangibles
 
Developed technology
12,100

Trademarks
700

Customers Lists
400

Goodwill
2,555

 
 
Total assets acquired
$
18,500

The following table summarizes the purchase price allocated to the assets acquired from BD (in thousands):
Inventories
$
5,804

Property and equipment
748

Intangibles
 
Developed technology
74,000

Customer list
4,200

Trademarks
4,900

In-process technology
2,500

Goodwill
9,728

 
 
Total assets acquired
$
101,880

The following table summarizes the purchase price allocated to the net assets acquired and liabilities assumed (in thousands):
Intangibles
 
Developed technology
$
7,800

In-process technology
920

Goodwill
4,281

Deferred tax liabilities
(3,101
)
 
 
Total net assets acquired
$
9,900

The following table summarizes the purchase price allocated to the assets acquired (in thousands):
 
Inventories
$
979

 
Property and equipment
58

 
Intangibles
 
 
Developed technology
5,400

 
Customer list
200

 
Goodwill
203

 
 
 
 
Total net assets acquired
$
6,840

The following table summarizes the preliminary purchase price allocated to the net assets acquired from Cianna Medical (in thousands):
Assets Acquired
 
Trade receivables
$
6,151

Inventories
5,803

Prepaid expenses and other assets
315

Property and equipment
1,047

Other long-term assets
14

Intangibles
 
Developed technology
134,510

Customer lists
3,330

Trademarks
7,080

Goodwill
65,885

Total assets acquired
224,135

 
 
Liabilities Assumed
 
Trade payables
(1,497
)
Accrued expenses
(2,384
)
Other long-term liabilities
(1,527
)
Deferred tax liabilities
(30,363
)
Total liabilities assumed
(35,771
)
 
 
Total net assets acquired
$
188,364

Business Acquisition, Pro Forma Information The following table summarizes our consolidated results of operations for the years ended December 31, 2018, 2017 and 2016, as well as unaudited pro forma consolidated results of operations as though the DFINE acquisition had occurred on January 1, 2015, the acquisition of the Argon critical care division had occurred on January 1, 2016 and the acquisition of Cianna Medical and Vascular Insights had occurred on January 1, 2017 (in thousands, except per common share amounts):
 
2018
 
2017
 
2016
 
As Reported
 
Pro Forma
 
As Reported
 
Pro Forma
 
As Reported
 
Pro Forma
Net sales
$
882,753

 
$
928,336

 
$
727,852

 
$
768,571

 
$
603,838

 
$
664,366

Net income (loss)
42,017

 
20,699

 
27,523

 
(13,720
)
 
20,121

 
23,054

Earnings per common share:
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.80

 
$
0.40

 
$
0.56

 
$
(0.28
)
 
$
0.45

 
$
0.52

Diluted
$
0.78

 
$
0.38

 
$
0.55

 
$
(0.27
)
 
$
0.45

 
$
0.51